By The Online Investor Staff, updated Fri., May. 27, 11:53 PM
Slide #1. Reata Pharmaceuticals, Inc. — Initial Public Offering
||Reata Pharmaceuticals, Inc.
|Price Per Share:
||Reata Pharmaceuticals, Inc. ("Reata"), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering of 5,500,000 shares of its Class A common stock at $11.00 per share, before underwriting discounts and commissions. Reata has granted the underwriters a 30-day option to purchase up to 825,000 additional shares of its Class A common stock at the initial public offering price. The shares of Class A common stock are expected to begin trading on The NASDAQ Global Market on May 26, 2016, under the ticker symbol "RETA."
IPOs: Reata Pharmaceuticals, Inc.
List of IPOs in this Slideshow:
Company Ticker IPO Date
The First of Long Island Corporation FLIC
Intellia Therapeutics, Inc. NTLA
Spring Bank Pharmaceuticals, Inc. SBPH
Turning Point Brands, Inc. TPB
SiteOne Landscape Supply, Inc. SITE
Oncobiologics, Inc. ONSIU
Pulse Biosciences, Inc. PLSE
PhaseRx, Inc. PZRX
Merus B.V. MRUS
Grupo Supervielle S.A. SUPV
Midland States Bancorp, Inc. MSBI
Cotiviti Holdings, Inc. COTV
US Foods Holding Corp. USFD
GMS Inc. GMS
Reata Pharmaceuticals, Inc. RETA
May 27, 2016 11:53 PM Eastern